Advancements in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

Preventing & Managing Hypoglycemia

In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education. They discuss: * Why hypoglycemia remains a major concern in insulin therapy * Key risk factors to keep in mind * Clinical signs or patient-reported symptoms * Prevention strategies * Importance of patient education * Balancing glycemic targets with hypoglycemia risk Prof. Simon Heller is Professor of Clinical Diabetes at the University of Sheffield, and Director of Research & Development at Sheffield Teaching Hospitals, NHS Foundation Trust. Explore more on the ATTD Education Portal [https://unlok-education.com/attd/]. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

Smart Tools & Technology for Better Insulin Outcomes

In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support. They discuss: * The new technologies making the biggest difference in insulin therapy today * The role of smart pens, connected devices, and apps * Biggest clinical impact - including adherence, titration and outcomes * Accessibility of these tools in real-world practice * Advisor role of AI * The promising future of technology in insulin therapy and a functional cure Professor Tadej Battelino is Co-Chair of ATTD and Chair of International Diabetes Federation Europe. Explore more on the ATTD Education Portal [https://unlok-education.com/attd/]. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

Fixed-Ratio Combinations (FRCs) in Practice

In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations. They discuss: * What exactly fixed-ratio combinations are and the problems they tackle * Identifying patient candidates and timelines for starting FRCs * Meaningful benefits of FRCs compared with basal insulin alone * Concerns and limitations of FRCs * How guideline recommendations currently position FRCs in diabetes management Dr George Grunberger, Chairman of the Grunberger Diabetes Institute in Michigan. George is also Clinical Professor of Internal Medicine at Wayne State University School of Medicine, and Professor of Internal Medicine at Oakland University William Beaumont School of Medicine. Explore more on the ATTD Education Portal [https://unlok-education.com/attd/]. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

Safe & Effective Insulin Titration Strategies

In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient. They discuss: * The importance of titration in successful insulin therapy * Barriers to titration, including patient self-management * How clinicians can collaborate with patients in their titration journey * The importance of language used by clinicians * Practical tips for simplifying titration in busy clinical settings Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, and Associate Clinical Professor in Psychiatry at the University of California. Explore more on the ATTD Education Portal [https://unlok-education.com/attd/]. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

Identifying Patients for Insulin Initiation in T2D

In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes. They discuss: * When clinicians should consider insulin for patients with T2D * Addressing concerns of weight gain with insulin * ADA/EASD recommendations * Barriers to insulin therapy and Type 2 diabetes * Advice on communication with patients Dr Osama Hamdy is Associate Professor of Medicine at Harvard Medical School, and Director of the Obesity Clinical Program at the Joslin Diabetes Center. Explore more on the ATTD Education Portal [https://unlok-education.com/attd/]. Register now to access exclusive content and stay ahead in the field! Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.